
    
      Number of Study Centres: 5 Duration of Study: 35 Months Criteria for Evaluation: Usability of
      the mHealth platform, patient self-management and empowerment, clinical safety (virological
      suppression maintenance, CD4 count, laboratory parameters, adverse events and adherence),
      quality of life and self-economy will be assessed by questionnaires and laboratory
      parameters.

      Routine data on patient demographics, treatment and investigations which will include viral
      load, CD4, haematology, biochemistry and urine sample. Patient Activation Measure, Quality of
      life, adherence questionnaire and economic questionnaires will be performed at baseline and
      at months 12 and 24. Satisfaction System Usability Scale will be evaluated at month 12 and
      24.
    
  